R-Chop With Or Without Lenalidomide/Bortezomib As A First Line Treatment For Patients With Non-Germinal Center Diffuse Large B Cell Lymphoma (Dlbcl) Subtype: Son Espases University Hospital Experience
BLOOD(2018)
摘要
INTRODUCTION
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要